[HTML][HTML] Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management

CX Ma, XN Ma, CH Guan, YD Li, D Mauricio… - Cardiovascular …, 2022 - Springer
Cardiovascular diseases (CVDs) are the main cause of death among patients with type 2
diabetes mellitus (T2DM), particularly in low-and middle-income countries. To effectively …

Insulin resistance and cardiovascular disease

CE Kosmas, MD Bousvarou… - Journal of …, 2023 - journals.sagepub.com
Insulin resistance (IR) and cardiovascular disease (CVD) represent two universal public
health hazards, especially in today's Western societies. A causal-effect relationship has …

Polyunsaturated fatty acids and metabolic health: novel insights

I Djuricic, PC Calder - Current Opinion in Clinical Nutrition & …, 2022 - journals.lww.com
Polyunsaturated fatty acids and metabolic health: novel insi... : Current Opinion in Clinical
Nutrition & Metabolic Care Polyunsaturated fatty acids and metabolic health: novel insights …

Association between uric acid to HDL cholesterol ratio and diabetic complications in men and postmenopausal women

Y Xuan, W Zhang, Y Wang, B Wang, F Xia… - Diabetes, Metabolic …, 2023 - Taylor & Francis
Aim Previous studies have implicated the uric acid to high-density lipoprotein cholesterol
(HDL-C) ratio (UHR) was associated with type 2 diabetes. However, the association …

[HTML][HTML] Triglyceride-rich lipoproteins and their remnants as silent promoters of atherosclerotic cardiovascular disease and other metabolic disorders: a review

R Sascău, A Clement, R Radu, C Prisacariu… - Nutrients, 2021 - mdpi.com
While targeting elevated serum levels of low-density lipoprotein cholesterol has been the
mainstay of atherosclerosis prevention and treatment for decades, the evidence regarding …

[HTML][HTML] The Na+/K+-ATPase: A potential therapeutic target in cardiometabolic diseases

M Obradovic, E Sudar-Milovanovic, Z Gluvic… - Frontiers in …, 2023 - frontiersin.org
Cardiometabolic diseases (CMD) are a direct consequence of modern living and contribute
to the development of multisystem diseases such as cardiovascular diseases and diabetes …

[HTML][HTML] Targeting trimethylamine N-oxide: A new therapeutic strategy for alleviating atherosclerosis

L Jing, H Zhang, Q Xiang, L Shen, X Guo… - Frontiers in …, 2022 - frontiersin.org
Atherosclerosis is one of the most common cardiovascular diseases, there is currently no
effective drug to reverse its pathogenesis. Trimethylamine N-oxide (TMAO) is one of the …

Cardiovascular outcomes and mortality after bariatric surgery in patients with nonalcoholic fatty liver disease and obesity

A Krishnan, Y Hadi, SA Alqahtani, TA Woreta… - JAMA Network …, 2023 - jamanetwork.com
Importance Bariatric surgery (BS) is associated with significantly reduced incidence of
cardiovascular diseases and mortality in patients with obesity. However, whether BS can …

[HTML][HTML] Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)

M Banach, S Surma, Z Reiner, N Katsiki… - Cardiovascular …, 2022 - Springer
Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled
worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol …

[HTML][HTML] The hypolipidemic effect of hawthorn leaf flavonoids through modulating lipid metabolism and gut microbiota in hyperlipidemic rats

H Hu, J Weng, C Cui, F Tang, M Yu, Y Zhou… - Evidence-Based …, 2022 - hindawi.com
Objective. The purpose of this study was to explore the potential mechanisms of the lipid-
regulating effects and the effect on modulating the gut microbiota of hawthorn leaf flavonoids …